22.06.2017 • News

Bayer Says EU Talks over Monsanto “Constructive”

Baumann said he is “confident” that the German group will be able to wrap...
Baumann said he is “confident” that the German group will be able to wrap up the deal by the end of this year, as planned.

Bayer’s talks with European Commission competition authorities about its plan to acquire US rival Monsanto have been good and “constructive” thus far, CEO Werner Baumann told journalists this week. Baumann said he is “confident” that the German group will be able to wrap up the deal by the end of this year, as planned.

The CEO said also that Bayer expects to be able to file for regulatory approval in Europe by the end of June, repeating earlier predictions that EU officials are likely to open an in-depth analysis into the plans for the mega merger that would create the world’s largest seeds and crop protection company.

In May, Bayer suggested it would be willing to divest its leading crop protection brand Liberty Link, which includes a herbicide and seeds, to comply with South Africa’s concerns. Authorities there feared concentration in the market for GM cotton seeds. Observers took the remarks to mean the group would shed the business globally, as its importance transcends the South African market.

South Africa has provisionally given thumbs up on the merger, becoming the first competition authority to do so.  Altogether, Bayer and Monsanto are expected to have to sell assets worth about $2.5 billion to gain clearance in all global markets.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.